Effects of dasatinib on EphA2 receptor tyrosine kinase activity and downstream signalling in pancreatic cancer. (Q36936023)
scientific article published on 16 September 2008
Language:
(P31) (Q13442814)
(P50) (Q54282536)
(P304) 1074-1082
(P407) (Q1860)
(P433) 7
(P478) 99
(P577) Tuesday, September 16, 2008
(P921) (Q419940)
(Q27139135)
(P1433) (Q326309)
(P1476) "Effects of dasatinib on EphA2 receptor tyrosine kinase activity and downstream signalling in pancreatic cancer" (language: en)
(P2093) Q Chang
C Jorgensen
T Pawson
(P2860) (Q40042764)
(Q34005966)
(Q40106672)
(Q40158315)
(Q40164471)
(Q40200272)
(Q37370600)
(Q40213644)
(Q28246193)
(Q35060278)
(Q35088031)
(Q40366043)
(Q40385854)
(Q40390348)
(Q40405920)
(Q36126549)
(Q40527387)
(Q40535880)
(Q40536598)
(Q30014833)
(Q24684095)
(Q28185509)
(Q30164872)
(Q34173522)
(Q40682090)
(Q28210840)
(Q34872708)
(Q40714708)
(Q28208291)
(Q40769069)
(Q40808897)
(Q34103639)
(Q28144113)
(Q22011187)
(Q24532273)
(Q40948859)
(Q28242069)
(Q28305007)
(Q40416594)
(Q42498441)
(Q42795950)
(Q55115709)
(Q46653193)
(Q45198729)
(Q47683124)
(Q44761792)
(Q44308408)
(Q44259057)
(Q44172489)
(Q43998986)
(Q43644678)
(Q43561178)
(Q46699319)
(Q73053220)
other details
description scientific article published on 16 September 2008

External Links